StockNews.com Begins Coverage on Galmed Pharmaceuticals (NASDAQ:GLMD)
StockNews.com started coverage on shares of Galmed Pharmaceuticals (NASDAQ:GLMD – Free Report) in a research report sent to investors on Thursday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Galmed Pharmaceuticals Stock Performance Shares of GLMD stock opened at $0.28 on Thursday. The firm’s 50-day simple moving average is $0.37 and […]
More Stories
StockNews.com Begins Coverage on The LGL Group (NYSE:LGL)
StockNews.com started coverage on shares of The LGL Group (NYSE:LGL – Free Report) in a research note published on Saturday...
Intercontinental Exchange (NYSE:ICE) Stock Rating Upgraded by The Goldman Sachs Group
Intercontinental Exchange (NYSE:ICE – Get Free Report) was upgraded by investment analysts at The Goldman Sachs Group from a “neutral”...
MiX Telematics (NYSE:MIXT) Now Covered by StockNews.com
StockNews.com started coverage on shares of MiX Telematics (NYSE:MIXT – Free Report) in a research report sent to investors on...
Cedar Fair (NYSE:FUN) PT Raised to $65.00 at Morgan Stanley
Cedar Fair (NYSE:FUN – Get Free Report) had its target price lifted by equities research analysts at Morgan Stanley from...
STERIS’ (TSE:STE) Forecasted to Post Q4 2025 Earnings of $0.03 Per Share
STERIS’ (TSE:STE – Free Report) – Atb Cap Markets reduced their Q4 2025 earnings per share (EPS) estimates for STERIS’...
Paychex, Inc. (NASDAQ:PAYX) Expected to Earn Q3 2025 Earnings of $1.49 Per Share
Paychex, Inc. (NASDAQ:PAYX – Free Report) – Research analysts at William Blair increased their Q3 2025 earnings per share estimates...